Milan, Italy · Founded 2009 · Privately Held (backing)
Developer of a medical platform designed to provide a targeted approach in the treatment of cancer. BetaGlue Therapeutics is based in Milan, Italy and was founded in 2009. Its last reported valuation was $25.3 million in Jul 2022. It has raised $49 million.
Last reported valuation
$25.3M
Oct 2026
Priced at
—
Total raised
$49.0M
Last round
—
Cap table — not yet on record
BetaGlue Therapeutics's share-class structure hasn't surfaced in our sources yet. Cap tables are assembled from certificates of incorporation, round filings, and disclosures as they land.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of BetaGlue Therapeutics with a free account
·The complete investor list: 14 names
·Watch BetaGlue Therapeutics: the Monday email on marks, rounds and moves
